22:
203:
Philippidis, Alex (1 January 2023). "BMS Collaboration Paying Off for
Exscientia: AI drug developer designs EXS4318, the I&I small molecule that has entered Phase I trials overseen by pharma giant in up-to-$ 1.3B+ partnership".
149:
Lv, Qi; Zhou, Feilong; Liu, Xinhua; Zhi, Liping (2023). "Artificial intelligence in small molecule drug discovery from 2018 to 2023: Does it really work?".
114:
Brady, Linda S.; Lisanby, Sarah H.; Gordon, Joshua A. (2023). "New directions in psychiatric drug development: promising therapeutics in the pipeline".
176:
Mak, Kit-Kay; Balijepalli, Madhu
Katyayani; Pichika, Mallikarjuna Rao (2022). "Success stories of AI in drug discovery - where do things stand?".
237:
242:
94:
90:
86:
32:
74:
131:
213:
185:
158:
123:
82:
78:
231:
189:
127:
162:
51:
135:
41:
217:
21:
97:
trial in one year, compared to an industry average of 4–6 years.
15:
85:
agonist. It is under development for psychosis related to
46:
36:
93:that enabled it to proceed from discovery to
8:
106:
7:
14:
178:Expert Opinion on Drug Discovery
116:Expert Opinion on Drug Discovery
20:
89:. The drug was developed using
1:
190:10.1080/17460441.2022.1985108
128:10.1080/17460441.2023.2224555
163:10.1016/j.bioorg.2023.106894
259:
77:modulator that acts as a
91:artificial intelligence
35:, as no other articles
218:10.1089/genedge.5.1.31
151:Bioorganic Chemistry
87:Alzheimer's disease
238:5-HT2A antagonists
75:serotonin receptor
54:for suggestions.
44:to this page from
68:
67:
250:
222:
221:
200:
194:
193:
173:
167:
166:
146:
140:
139:
111:
63:
60:
49:
47:related articles
24:
16:
258:
257:
253:
252:
251:
249:
248:
247:
243:5-HT2A agonists
228:
227:
226:
225:
202:
201:
197:
175:
174:
170:
148:
147:
143:
113:
112:
108:
103:
83:5-HT1A receptor
81:antagonist and
79:5-HT2A receptor
64:
58:
55:
45:
42:introduce links
25:
12:
11:
5:
256:
254:
246:
245:
240:
230:
229:
224:
223:
212:(1): 147–150.
195:
168:
141:
122:(8): 835–850.
105:
104:
102:
99:
66:
65:
52:Find link tool
28:
26:
19:
13:
10:
9:
6:
4:
3:
2:
255:
244:
241:
239:
236:
235:
233:
219:
215:
211:
207:
199:
196:
191:
187:
183:
179:
172:
169:
164:
160:
156:
152:
145:
142:
137:
133:
129:
125:
121:
117:
110:
107:
100:
98:
96:
92:
88:
84:
80:
76:
72:
62:
59:November 2023
53:
48:
43:
39:
38:
34:
29:This article
27:
23:
18:
17:
209:
205:
198:
184:(1): 79–92.
181:
177:
171:
154:
150:
144:
119:
115:
109:
70:
69:
56:
30:
232:Categories
157:: 106894.
101:References
50:; try the
37:link to it
136:1746-0441
40:. Please
206:GEN Edge
71:DSP-0038
95:Phase I
134:
33:orphan
31:is an
73:is a
132:ISSN
214:doi
186:doi
159:doi
155:141
124:doi
234::
208:.
182:17
180:.
153:.
130:.
120:18
118:.
220:.
216::
210:5
192:.
188::
165:.
161::
138:.
126::
61:)
57:(
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
